Mihika Pharmaceuticals is a finished-dose manufacturer based in India. It appears in 2 regulatory filings across 2 regulators, without an active US DMF or CEP on file. Its filings concentrate with NAFDAC (NG) and ZAMRA (ZM). Its GMP standing is certified by CDSCO (India) and NAFDAC (NG). Customs aggregates show $4.3M of exports covering 552 molecules to 7 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Valsad, India | Not on file |
| valsad 396 125, India | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| NAFDAC (NG) | 1 | 1 |
| ZAMRA (ZM) | 1 | None |
| CDSCO (India) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $828K | 5 |
| 2025 | Not reported | $4.3M | 7 |
| 2024 | Not reported | $4.1M | 10 |
| 2023 | Not reported | $3.2M | 8 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Mihika Pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free